Information Journal Paper
APA:
CopyMOURET REYNIER, M.A., ABRIAL, C.J., & FERRIERE, J.P.. (2004). NEOADJUVANT FEC 100 FOR OPERABLE BREAST CANCER: EIGHT-YEAR EXPERIENCE AT CENTRE JEAN PERRIN. CLINICAL BREAST CANCER, 5(4), 303-307. SID. https://sid.ir/paper/591661/en
Vancouver:
CopyMOURET REYNIER M.A., ABRIAL C.J., FERRIERE J.P.. NEOADJUVANT FEC 100 FOR OPERABLE BREAST CANCER: EIGHT-YEAR EXPERIENCE AT CENTRE JEAN PERRIN. CLINICAL BREAST CANCER[Internet]. 2004;5(4):303-307. Available from: https://sid.ir/paper/591661/en
IEEE:
CopyM.A. MOURET REYNIER, C.J. ABRIAL, and J.P. FERRIERE, “NEOADJUVANT FEC 100 FOR OPERABLE BREAST CANCER: EIGHT-YEAR EXPERIENCE AT CENTRE JEAN PERRIN,” CLINICAL BREAST CANCER, vol. 5, no. 4, pp. 303–307, 2004, [Online]. Available: https://sid.ir/paper/591661/en